Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-03-01
|
| Series: | Pathology and Oncology Research |
| Subjects: | |
| Online Access: | https://www.por-journal.com/articles/10.3389/pore.2024.1611758/full |
| _version_ | 1797224740672241664 |
|---|---|
| author | Peter Batar Hussain Alizadeh Gyorgy Rokszin Zsolt Abonyi-Toth Zsolt Abonyi-Toth Judit Demeter |
| author_facet | Peter Batar Hussain Alizadeh Gyorgy Rokszin Zsolt Abonyi-Toth Zsolt Abonyi-Toth Judit Demeter |
| author_sort | Peter Batar |
| collection | DOAJ |
| first_indexed | 2024-04-24T13:57:55Z |
| format | Article |
| id | doaj.art-7ea3a430a7854d158216f0fc7e1015cd |
| institution | Directory Open Access Journal |
| issn | 1532-2807 |
| language | English |
| last_indexed | 2024-04-24T13:57:55Z |
| publishDate | 2024-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Pathology and Oncology Research |
| spelling | doaj.art-7ea3a430a7854d158216f0fc7e1015cd2024-04-03T15:51:36ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072024-03-013010.3389/pore.2024.16117581611758Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from HungaryPeter Batar0Hussain Alizadeh1Gyorgy Rokszin2Zsolt Abonyi-Toth3Zsolt Abonyi-Toth4Judit Demeter5Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary1st Department of Medicine, Division of Haematology, Clinical Center, Medical School, University of Pecs, Pecs, HungaryRxTarget Ltd., Szolnok, HungaryRxTarget Ltd., Szolnok, HungaryDepartment of Biostatistics, University of Veterinary Medicine, Budapest, HungaryDepartment of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungaryhttps://www.por-journal.com/articles/10.3389/pore.2024.1611758/fullchronic myeloid leukemiareal-word evidencetyrosine kinase inhibitorstreatment outcomeoverall survival |
| spellingShingle | Peter Batar Hussain Alizadeh Gyorgy Rokszin Zsolt Abonyi-Toth Zsolt Abonyi-Toth Judit Demeter Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary Pathology and Oncology Research chronic myeloid leukemia real-word evidence tyrosine kinase inhibitors treatment outcome overall survival |
| title | Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary |
| title_full | Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary |
| title_fullStr | Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary |
| title_full_unstemmed | Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary |
| title_short | Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary |
| title_sort | corrigendum comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors a real world nationwide retrospective study from hungary |
| topic | chronic myeloid leukemia real-word evidence tyrosine kinase inhibitors treatment outcome overall survival |
| url | https://www.por-journal.com/articles/10.3389/pore.2024.1611758/full |
| work_keys_str_mv | AT peterbatar corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary AT hussainalizadeh corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary AT gyorgyrokszin corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary AT zsoltabonyitoth corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary AT zsoltabonyitoth corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary AT juditdemeter corrigendumcomorbiditiesandoutcomesofpatientswithchronicmyeloidleukemiatreatedwithtyrosinekinaseinhibitorsarealworldnationwideretrospectivestudyfromhungary |